tiprankstipranks
Trending News
More News >
HBM Holdings Ltd. (HK:2142)
:2142
Hong Kong Market

HBM Holdings Ltd. (2142) Similar Stocks

Compare
6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
HBM Holdings Ltd.
HK$13.34
HK$11.78B
18.05
895.52%
0 Buy
0 Hold
0 Sell
Moderate Buy
Alphamab Oncology
HK$10.91
HK$10.63B
41.59
215.32%
2 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$5.43
HK$10.09B
-48.22
82.21%
1 Buy
0 Hold
0 Sell
Moderate Buy
Abbisko Cayman Limited
HK$13.48
HK$9.17B
48.16
209.17%
5 Buy
0 Hold
0 Sell
Strong Buy
CStone Pharmaceuticals
HK$6.02
HK$8.75B
-19.31
161.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.98
HK$5.59B
145.31
2.28%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2142
HBM Holdings Ltd.
13.34
11.92
839.44%
HK:9966
Alphamab Oncology
10.91
7.51
220.88%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.43
2.78
104.91%
HK:2256
Abbisko Cayman Limited
13.48
9.12
209.17%
HK:2616
CStone Pharmaceuticals
6.02
3.66
155.08%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.98
0.12
1.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts